A clinical drug trial to study the effectiveness of bee pollen capsules in patients suffering from oral submucous fibrosis.
- Conditions
- Health Condition 1: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2021/02/031377
- Lead Sponsor
- Dr Divya Dube
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
1.Clinically diagnosed grade I. grade II, grade III, oral submucous fibrosis patients according to Khanna and Andrade (1995) classification.
2.Patients who has quit the habit of areca nut.
3.Patientsbelow 12 years of age and above 12 years of age.
4.Patients with visual analog scale (VAS) score below 6
5.Patients who were willing to participate in the study.
1.Individuals with history of treatment and undergoing treatment for oral submucous fibrosis.
2.Patients with any oral or systemic diseases and/or any medications
3.Patients diagnosed with grade IV cases of OSMF according to Khanna and Andrade classification.
4.Pregnant and lactating women.
5.Patients with VAS score above 6.
6.History of hypersensitivity to bee products or any other medications.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method